OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease
Abdul Naeem, Ravi Prakash, Neha Kumari, et al.
Brain Behavior and Immunity (2023) Vol. 116, pp. 70-84
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 129

Role of NLRP3 inflammasome in central nervous system diseases
Lu Zhang, Yufen Tang, Peng Huang, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 12

H4K12 lactylation-regulated NLRP3 is involved in cigarette smoke-accelerated Alzheimer-like pathology through mTOR-regulated autophagy and activation of microglia
Hailan Wang, Haibo Xia, Jun Bai, et al.
Journal of Hazardous Materials (2025) Vol. 488, pp. 137310-137310
Closed Access | Times Cited: 1

Reactive Oxygen Species as a Common Pathological Link Between Alcohol Use Disorder and Alzheimer’s Disease with Therapeutic Implications
Ho-Young Song, Jiyong Lee, Yeeun Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3272-3272
Open Access | Times Cited: 1

Dihydrocapsaicin suppresses the STING‐mediated accumulation of ROS and NLRP3 inflammasome and alleviates apoptosis after ischemia–reperfusion injury of perforator skin flap
Yingying Lai, Ningning Yang, Xuankuai Chen, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 5, pp. 2539-2559
Closed Access | Times Cited: 7

The research trends and hotspots of NLRP3 inflammasome in Alzheimer's disease: a bibliometric and visualization analysis
Xuanwei Wen, Huiye Yang, Shuangxi Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Rahul Mallick, Sanjay Basak, Parimal Chowdhury, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 104-104
Open Access

Intermittent Fasting Improves Sevoflurane-Induced Cognitive Dysfunction in Rats Through SIRT1-Mediated Autophagy
Feng-wei Sun, Yue Tian
Neurochemical Research (2025) Vol. 50, Iss. 1
Closed Access

Inhibition of NLRP3 enhances pro-apoptotic effects of FLT3 inhibition in AML
Helene Sieberer, Michela Luciano, Diana Amend, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access

NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Wen Xu, Yi Huang, Rongbin Zhou
Cellular and Molecular Immunology (2025)
Open Access

Lycium ruthenium anthocyanins attenuate acrylamide-induced neuroinflammation via gut microbiota-mediated NLRP3 inflammasome
Xuemei Qin, Hanqing Guo, Qingqing Luo, et al.
Food Bioscience (2025), pp. 106516-106516
Closed Access

Decoding NLRP3 Inflammasome Activation in Alzheimer’s Disease: A Focus on Receptor Dynamics
Ranika Maurya, Abha Sharma, Saba Naqvi
Molecular Neurobiology (2025)
Closed Access

Mitophagy in Brain Injuries: Mechanisms, Roles, and Therapeutic Potential
Jiayu Tian, Yanna Mao, Di Liu, et al.
Molecular Neurobiology (2025)
Open Access

Neuroprotective potential of tranilast in streptozotocin-induced sporadic Alzheimer's disease model targeting TXNIP-NLRP3 inflammasome pathway
Dibya Sundar Padhy, Kushal Vesmaker, Sugato Banerjee
International Immunopharmacology (2025) Vol. 156, pp. 114691-114691
Closed Access

Interaction of obesity and proteins associated with the NLRP3 inflammasome following mild traumatic brain injury
Shawn R. Eagle, Mahesh Kumar Basantani, Jonathan Preszler, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions
Yujia Zheng, Xiaolu Zhang, Ziyu Wang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Closed Access | Times Cited: 3

Therapeutic role of NLRP3 inflammasome inhibitors against Alzheimer’s disease
Tanmoy Tantra, Abdul Rahaman T A, Nandini Nandini, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107912-107912
Closed Access | Times Cited: 3

Advancements in programmed cell death research in antitumor therapy: a comprehensive overview
Shuxin Wei, Chuangye Han, Shutian Mo, et al.
APOPTOSIS (2024)
Closed Access | Times Cited: 3

Activation of NLRP3 inflammasome in a rat model of cerebral small vessel disease
Meiyan Zhang, Xiaoyan Lan, Yue Gao, et al.
Experimental Brain Research (2024) Vol. 242, Iss. 6, pp. 1387-1397
Closed Access | Times Cited: 2

Injectable bioresponsive bone adhesive hydrogels inhibit NLRP3 inflammasome on demand to accelerate diabetic fracture healing
Xianglong Xing, Z.F. Gong, Chao Chen, et al.
Biomaterials (2024) Vol. 317, pp. 123059-123059
Closed Access | Times Cited: 2

The role of macrophage plasticity in neurodegenerative diseases
Hongyue Ma, Mingxia Zhu, Mengjie Chen, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1

Inflammasomes in neurodegenerative diseases
Qianchen Wang, Songwei Yang, Xuan Zhang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Statins for vascular dementia: A hype or hope
Haroon Raja, Hayder M. Al‐kuraishy, Mustafa M Shokr, et al.
Neuroscience (2024) Vol. 567, pp. 45-55
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top